Rhythm Pharmaceuticals Inc (NAS:RYTM)
$ 55.59 -0.95 (-1.68%) Market Cap: 3.47 Bil Enterprise Value: 3.14 Bil PE Ratio: 0 PB Ratio: 308.96 GF Score: 58/100

Q1 2024 Rhythm Pharmaceuticals Inc Earnings Call Transcript

May 07, 2024 / 12:00PM GMT
Release Date Price: $39.35 (-10.32%)
Operator

Good day, and thank you for standing by, and welcome to the Rhythm Pharmaceuticals Q1 2024 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, David Connolly, Executive Director of Investor Relations and Corporate Communications. Please go ahead.

David Connolly
Rhythm Pharmaceuticals Inc - Executive Director, IR and Corporate Communications

Thank you, Steven. I'm Dave Connolly here at Rhythm Pharmaceuticals. For those of you participating on the conference call, o ur slides can be accessed and controlled by going to the Investors section on the investors page of our website, ir.rhythmtx.com. This morning, we issued our press release that provides our first quarter of 2024 financial results and business update, and that is available on our website.

As listed on slide 2 is our agenda. Here with me today in Boston are David Meeker, our Chairman, Chief Executive Officer, and President; Jennifer Lee, Executive Vice

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot